Chapman Financial Group, LLC Merck & Co., Inc. Transaction History
Chapman Financial Group, LLC
- $145 Billion
- Q3 2025
A detailed history of Chapman Financial Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Chapman Financial Group, LLC holds 2,743 shares of MRK stock, worth $254,714. This represents 0.16% of its overall portfolio holdings.
Number of Shares
2,743
Previous 1,065
157.56%
Holding current value
$254,714
Previous $84.3 Million
173.08%
% of portfolio
0.16%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding MRK
# of Institutions
3,875Shares Held
1.9BCall Options Held
30.1MPut Options Held
27.7M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...